Cargando…
Effectiveness of REGEN-COV antibody combination to reduce risk of hospitalization for pregnant patients with COVID-19
Autores principales: | F, Williams, J, Morgan, J, Martin, N, Mussarat, A, Elmayan, J, Biggio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836196/ http://dx.doi.org/10.1016/j.ajog.2022.11.157 |
Ejemplares similares
-
Effectiveness of REGEN-COV combination monoclonal antibody infusion to reduce the risk of COVID-19 hospitalization in pregnancy: a retrospective cohort study
por: Williams, Frank B., et al.
Publicado: (2023) -
Sociodemographic Determinants of COVID-19 Susceptibility and Outcomes in the Pregnant Population
por: Mussarat, Naiha, et al.
Publicado: (2022) -
Timing of COVID-19 as a Predictor of Adverse Neonatal Outcomes
por: Mussarat, Naiha, et al.
Publicado: (2022) -
Risk for stillbirth following maternal COVID-19 in otherwise low risk pregnancies
por: Puri, Priya M., et al.
Publicado: (2023) -
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
por: Weinreich, David M., et al.
Publicado: (2021)